Department Overview

The Oncology Department at Imperial Medicare Centre is a comprehensive cancer care center offering state-of-the-art diagnosis, treatment, and supportive care for all types of cancer. Our multidisciplinary team of oncologists, surgeons, radiologists, and support staff work together to provide personalized treatment plans.

We utilize advanced treatment modalities including precision radiation therapy, targeted chemotherapy, immunotherapy, and minimally invasive surgical techniques. Our department features a fully equipped radiation oncology unit, chemotherapy day care, and dedicated oncology wards.

Our patient-centered approach focuses not only on treating cancer but also on improving quality of life through pain management, nutritional support, psychological counseling, and rehabilitation services.

Lung Cancer
Breast Cancer
Brain Tumors
Colorectal Cancer
Blood Cancers
Prostate Cancer

Advanced Treatment: Precision Radiation Therapy

Our department offers IMRT, IGRT, and SBRT techniques that deliver high-dose radiation to tumors while sparing surrounding healthy tissue, improving treatment outcomes and reducing side effects.

25+ Oncology Experts
98% Accuracy Rate
24/7 Support Care

Cancer Care & Treatments

Solid Tumors

Breast, lung, colon, prostate, and other solid organ cancers requiring comprehensive management.

Our Treatment

Surgical oncology, precision radiation, targeted therapy, and multidisciplinary tumor boards.

Hematological Cancers

Leukemia, lymphoma, myeloma, and other blood and bone marrow cancers.

Our Treatment

Chemotherapy, stem cell transplantation, immunotherapy, and targeted molecular therapy.

Treatment Side Effects

Nausea, fatigue, pain, and other complications from cancer treatments affecting quality of life.

Our Support

Comprehensive supportive care, pain management, nutritional support, and rehabilitation services.

Cancer Recurrence

Return of cancer after initial treatment requiring specialized management and surveillance.

Our Approach

Advanced surveillance protocols, second-line treatments, and clinical trial opportunities.